250
Participants
Start Date
October 31, 2025
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
HM15275
HM15275 is a sterile solution for subcutaneous injection, supplied pre-filled syringes.
Placebo of HM15275
A sterile, matching solution supplied in pre-filled syringes.
Accellacare of Winston Salem, Winston-Salem
Accellacare of Cary - Cary Medical Group, Cary
Raleigh Medical Group, P.A., Raleigh
Accellacare of Wilmington, LLC, Wilmington
Accellacare of Hickory, Hickory
Accellacare of Piedmont - Piedmont HealthCare, Statesville
Accellacare of Charleston, Mt. Pleasant
Accellacare of Bristol-PAC of Tennessee, Bristol
Bristol-Internal Medicine and Pediatric Associates of Bristol, P.C., Bristol
Accellacare of McFarland, Ames
Accellacare of Duly - Duly Oak Lawn, Oak Lawn
Velocity Clinical Research, Dallas, Dallas
Lead Sponsor
Hanmi Pharmaceutical Company Limited
INDUSTRY